Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




RF Ablation Minimally Invasive Alternative for Liver Cancer

By HospiMedica staff writers
Posted on 28 Feb 2005
Radiofrequency (RF) ablation provides effective treatment for some patients who have inoperable liver tumors, according to two new studies published in the March 2005 issue of the journal Radiology.

"I believe that this treatment will soon enter into the guidelines for the clinical management of liver cancer patients,” said Riccardo Lencioni, M.D., a radiology professor at the University of Pisa (Italy), and the first study's lead author.

Surgical resection is believed to be the best hope for a cure. More...
The downside of this procedure, however, is that most patients do not meet the surgical requirements. Liver transplantations can be performed on only a small number of patients, organ supply is limited, and tumor progression during the long waiting times results in a high dropout rate. As a result, RF ablation has become an alternative treatment option for inoperable liver cancer, and may be useful as a bridge to liver transplantation. RF ablation is a minimally invasive procedure where an interventional radiologist used an image-guided electrode needle to deliver heat directly to the tumor, essentially "cooking” it.

In the first study, Dr. Lencioni and coworkers performed RF ablation on 187 early-stage cancer patients with cirrhosis who are not eligible for surgery. Individuals with hepatitis B, C, or cirrhosis are at increased risk of developing liver cancer. Less than 5% of liver-cancer patients with cirrhosis are eligible for surgical liver resection. "RF ablation was shown to be a safe therapeutic option, with no treatment-induced mortality and a complication rate below 2%,” Dr. Lencioni said.

After one year, 97% of the patients survived, 71% survived after three years, and 48% survived after five years, which is comparable to results obtained with surgical resection in this kind of patient. The findings also indicate that patient survival with RF ablation is dependent on the type of cirrhosis and number of tumors present.

"The results that we have reported are very promising,” Dr. Lencioni said. "However, they can only be obtained when the diagnosis of liver cancer is made at an early, asymptomatic stage. It is of the utmost importance that all patients with chronic hepatitis or cirrhosis--who are known to be at risk to develop liver cancer--are carefully monitored for timely detection of the emergence of a tumor.”

The second study published in Radiology additionally shows the effectiveness of RF ablation in treating liver tumors. "We have unequivocally demonstrated that RF ablation is highly capable of complete tumor destruction for small liver cancer nodules,” said David S.K. Lu, M.D., professor of radiology and director of the image-guided tumor ablation program at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA: CA, USA).

In this study, UCLA investigators used RF ablation to treat 47 liver cancer nodules in 24 patients who were waiting for liver transplantation. After transplantation, pathologic examinations of the diseased livers were performed to retrospectively assess the effectiveness of RF. The researchers found that 74% of the tumors were effectively treated by ablation. The procedure was more successful with smaller tumors than with larger tumors, with a success rate of 83% when treating tumors 3 cm or smaller.

According to Dr. Lu, not all tumors can be treated in this way. "It is important to discuss treatment options with a hepatologist or oncologist and to seek consultation with an interventional radiologist experienced in tumor ablation,” he said.



Related Links:
University of Pisa
University of California, Los Angeles

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.